- Federal agenciesEasier federal research and development: moving marijuana to Schedule III would reduce some administrative barriers to…
- Federal agenciesReduced federal criminal penalties and enforcement scope: many federal offenses and sentencing enhancements tied to Sch…
- Potential benefitImproved access to banking and financial services for cannabis businesses: removing the Schedule I classification could…
Marijuana 1-to-3 Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for co…
This bill (Marijuana 1-to-3 Act of 2025) directs the Attorney General to transfer marijuana from Schedule I to Schedule III of the Controlled Substances Act. The transfer must be completed by order within 60 days after enactment.
Scope of reform: liberals see rescheduling as progress but insufficient without expungement and equity measures; conservatives see it as too permissive.
Relative to its intended legislative type, this bill is a focused, single-action substantive change that clearly directs the Attorney General to reschedule marijuana to Schedule III within a short, specific timeframe but provides limited accompanying detail.
This bill (Marijuana 1-to-3 Act of 2025) directs the Attorney General to transfer marijuana from Schedule I to Schedule III of the Controlled Substances Act.
The transfer must be completed by order within 60 days after enactment.
The text contains no other changes to federal law, regulations, expungement, tax treatment, or state law; it only mandates the rescheduling action.
On content alone the bill is a straightforward administrative change with potentially large downstream effects; that narrowness improves tractability relative to sweeping reforms. Nevertheless, the subject is politically salient and polarizing enough to produce meaningful opposition and procedural obstacles in the Senate. The absence of compromise features or phased implementation increases the risk that it stalls in committee or on the floor despite its simplicity.
Relative to its intended legislative type, this bill is a focused, single-action substantive change that clearly directs the Attorney General to reschedule marijuana to Schedule III within a short, specific timeframe but provides limited accompanying detail.
Scope of reform: liberals see rescheduling as progress but insufficient without expungement and equity measures; conservatives see it as too permissive.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesDoes not legalize marijuana or resolve state-federal conflicts: critics may note rescheduling leaves marijuana federall…
- EmployersOngoing regulatory complexity and uncertainty: transitioning schedules would require new DEA/FDA/IRS guidance and could…
- Federal agenciesPublic health and safety concerns: some critics may argue that lowering federal scheduling could increase availability…
Why the argument around this bill splits.
Scope of reform: liberals see rescheduling as progress but insufficient without expungement and equity measures; conservatives see it as too permissive.
A mainstream liberal/left-leaning observer would view this bill as a positive, incremental federal step that reduces the legal classification that has been used to block research and justify harsh criminal penalties.
They would appreciate that it acknowledges medical use and lower abuse potential compared with Schedule I.
However, they would also note the bill fails to address key social-justice items (expungement, resentencing, collateral consequences) and other federal impediments to a functioning regulated market.
A mainstream centrist/moderate would likely view the bill as an incremental, pragmatic reform: it narrows the federal/drug classification without a sweeping overhaul.
They would appreciate the relatively narrow, administrable change and see potential benefits for research and regulatory clarity, while wanting more analysis of public-safety, fiscal, and administrative consequences.
They would likely support the step but press for legislative follow-up and clear implementation plans.
A mainstream conservative/right-leaning observer would likely oppose the bill or view it skeptically, seeing it as federal loosening of drug controls that could increase recreational use and harm public health and safety.
They would emphasize states' rights concerns about a federal signal that normalizes marijuana and worry about youth access, impaired driving, and workplace safety.
Some conservatives might accept modest changes to facilitate research but many would prefer retaining Schedule I or pursuing stricter regulatory/age-limited frameworks tied to states' discretion.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone the bill is a straightforward administrative change with potentially large downstream effects; that narrowness improves tractability relative to sweeping reforms. Nevertheless, the subject is politically salient and polarizing enough to produce meaningful opposition and procedural obstacles in the Senate. The absence of compromise features or phased implementation increases the risk that it stalls in committee or on the floor despite its simplicity.
- The bill text lacks a cost estimate or analysis of downstream fiscal impacts (e.g., tax revenue, enforcement savings, effects on existing federal programs), which can materially affect committee and floor support.
- The positions of key administrative actors (Department of Justice, FDA, Treasury) and major stakeholder groups (law enforcement organizations, medical associations, state governments) are unknown and could strongly influence legislative momentum.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Scope of reform: liberals see rescheduling as progress but insufficient without expungement and equity measures; conservatives see it as to…
On content alone the bill is a straightforward administrative change with potentially large downstream effects; that narrowness improves tr…
Relative to its intended legislative type, this bill is a focused, single-action substantive change that clearly directs the Attorney General to reschedule marijuana to Schedule III within a short, specific timeframe bu…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.